Aminov Erez's Form 4 filing
Mira Pharmaceuticals, Inc. (MIRA) · filed Nov 27, 2024
- Accession no.
- 0001493152-24-047998
- Filed
- Nov 27, 2024
- Trade date
- Nov 19-20, 2024
- Filing delay
- 8 daysLate
- Rule 10b5-1 plan
- Checked
This filing lists 2 non-derivative transactions and 0 derivative transactions. Open-market sales total $133.6K. It was filed 8 days after the trade, past the 2-business-day deadline.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Aminov ErezCIK 0001986112 | Director, Officer (Chief Executive Officer) |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Nov 19, 2024 | Common Stock | SSaleDisposed | −55,410 | $1.39 | −$77,019.9 | 1,105,790 | Direct | |
| Nov 20, 2024 | Common Stock | SSaleDisposed | −44,590 | $1.27 | −$56,629.3 | 1,061,200 | Direct |
Footnotes
Livermore does not store Form 4 footnotes. For price ranges, how indirect holdings are held and trading plan details, read the original on SEC EDGAR.